Showing results (341-350 of 349) with videos related to
Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 349 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 2020
Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II StudyErika J Lampert, Alexandra Zimmer, Michelle Padget, et al.Alcoholism, Clinical and Experimental Research|August 14, 2009
Suppression of heavy drinking and alcohol seeking by a selective ALDH-2 inhibitorMaria P Arolfo, David H Overstreet, Lina Yao, et al.JCI Insight|September 20, 2019
Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNKAmber J Giles, Shuyu Hao, Michelle Padget, et al.Science Immunology|December 12, 2025
Hypoxia-induced EGR1 remodels neutrophils to suppress antitumor immunityTian-Gen Chang, Jay Friedman, Paul E Clavijo, et al.Cancer Immunology, Immunotherapy : CII|November 6, 2009
Immunologic and prognostic factors associated with overall survival employing a poxviral-based PSA vaccine in metastatic castrate-resistant prostate cancerJames L Gulley, Philip M Arlen, Ravi A Madan, et al.Cancer|December 2, 2016
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning MeetingJulie E Bauman, Ezra Cohen, Robert L Ferris, et al.Journal for Immunotherapy of Cancer|March 27, 2020
Consensus guidelines for the definition, detection and interpretation of immunogenic cell deathLorenzo Galluzzi, Ilio Vitale, Sarah Warren, et al.Frontiers in Immunology|December 5, 2015
Molecular and Translational Classifications of DAMPs in Immunogenic Cell DeathAbhishek D Garg, Lorenzo Galluzzi, Lionel Apetoh, et al.Oncoimmunology|May 6, 2015
Consensus guidelines for the detection of immunogenic cell deathOliver Kepp, Laura Senovilla, Ilio Vitale, et al.Pageof 35